Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Immtech Pharmaceuticals and Beijing Capital Medical University in Beijing have signed a memorandum of understanding to develop a joint venture to provide contract research services in China.
Subscribe to our email newsletter
The joint venture (JV) will provide a range of services in drug discovery research for international companies and research organizations seeking to develop and market pharmaceutical products and biologics. The JV will be established later in 2008 and will provide services ranging from research planning and risk assessment through preclinical and clinical study design.
With an initial focus on early-stage drug discovery, the JV will also be positioned to support later-stage clinical development including coordination with research sites, data management, monitoring and reporting for clinical research programs. Expansion of the JV’s operation will include providing counsel and support related to clinical research regulatory guidelines and regulatory review procedures in China.
Eric Sorkin, chairman and CEO of Immtech, said: “By combining our complementary resources and expertise, we will deliver high-quality research services that will help companies to reduce the time and costs associated with drug discovery.”